On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica

FunderResearch funding and supported work

Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica is a funder indexed in ScholarIQ from OpenAlex.

How many works does Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica have?

ScholarIQindexed works

Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica has 121 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica?

ScholarIQopenalex

The OpenAlex for Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica is on the source record.

What are the most-cited papers on Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica?

ScholarIQmost cited works
Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis
Zili Zhang, Zhen Yao, Shifeng Zhao, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng
Cell Death and Disease. 201796 CitationsOPEN ACCESS
Dihydroartemisinin counteracts fibrotic portal hypertension <i>via</i> farnesoid X receptor‐dependent inhibition of hepatic stellate cell contraction
Wenxuan Xu, Chunfeng Lu, Feng Zhang, Jiangjuan Shao, Shunyu Yao, Shizhong Zheng
FEBS Journal. 201637 CitationsOPEN ACCESS
470M+ articles · 14-day free trial